ACUTAAS Chemicals Shareholders Approve Key Leadership Reappointments and Financial Statements
Acutaas Chemicals Limited held its 18th Annual General Meeting on September 25, 2025. Shareholders approved the reappointment of Nareshkumar Ramjibhai Patel as Managing Director and Executive Chairman, along with two Whole Time Directors for five-year terms. Two independent directors were also reappointed. The meeting adopted financial statements for FY 2024-25 and declared a final dividend of 30% (₹1.50 per equity share). Shareholders ratified cost auditors' remuneration and appointed new Secretarial Auditors.

*this image is generated using AI for illustrative purposes only.
Acutaas Chemicals Limited, a leading player in the specialty chemicals sector, held its 18th Annual General Meeting (AGM) on September 25, 2025, where shareholders approved several significant resolutions, including the reappointment of key leadership positions and the adoption of financial statements.
Leadership Continuity
The shareholders approved the reappointment of Nareshkumar Ramjibhai Patel as Managing Director and Executive Chairman for a five-year term from May 1, 2026, to April 30, 2031. This decision ensures continuity in the company's top leadership, with Patel bringing over two decades of experience in the chemical and pharma industry.
Additionally, Chetankumar Chhaganlal Vaghasia and Virendra Nath Mishra were reappointed as Whole Time Directors for five-year terms. Vaghasia's term will run from May 1, 2026, to April 30, 2031, while Mishra's term is set from April 1, 2026, to March 31, 2031.
Independent Director Reappointments
The meeting also saw the reappointment of two independent directors. Richa Manoj Goyal and Hetal Madhukant Gandhi were both approved for second terms of five consecutive years. Goyal, a practicing company secretary with over 20 years of experience in corporate laws and intellectual property rights, will serve from April 1, 2026, to March 31, 2031. Gandhi, a chartered accountant with three decades of experience in financial services, will serve from April 28, 2026, to April 27, 2031.
Financial Approvals and Dividend Declaration
Shareholders adopted the audited financial statements for the fiscal year ended March 31, 2025, along with the reports of the Board of Directors and Auditors. A final dividend of 30% (₹1.50 per equity share) for the financial year 2024-25 was declared, reflecting the company's strong financial performance.
Other Key Resolutions
The AGM also approved the ratification of remuneration for cost auditors for the financial year 2025-26 and the appointment of M/s KSPS & Co. LLP as the Secretarial Auditors of the company for a five-year term from FY 2025-26 to FY 2029-30.
Shareholder Participation and Voting
The meeting, conducted through video conferencing, saw active participation from shareholders. All resolutions were passed with significant majority, demonstrating strong shareholder support for the company's governance and strategic direction.
Acutaas Chemicals Limited's focus on maintaining leadership stability while ensuring robust corporate governance through the reappointment of experienced independent directors signals the company's commitment to sustained growth and shareholder value creation in the specialty chemicals sector.
Historical Stock Returns for Acutaas Chemicals
1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|
-3.76% | -6.86% | -3.93% | +14.06% | +55.70% | +190.50% |